Introduction
RPMI 1640, also known as RPMI Medium, was originally developed at Roswell Park Memorial Institute (RPMI) in 1966 for the growth of human leukemia cells in monolayer or suspension cultures. RPMI media has since been found to be suitable for a wide variety of mammalian and hybridoma cells. We offer a variety of RPMI media to meet the needs of your specific applications.
The P04-18525 RPMI 1640 has a very low endotoxin content.
Composition
PAN-Biotech RPMI 1640, w: stable Glutamine, w: 2.0 g/L NaHCO3, Very Low Endotoxin
Specifications
Cat. No. P04-18525
| Bicarbonate: | With 2.0 g/L Sodium Bicarbonate |
|---|---|
| Endotoxin Content: | Very low endotoxin content |
| Glucose: | With glucose |
| Glutamine: | With Stable Glutamine |
| HEPES: | Without HEPES |
| Liquid / Powder: | Liquid |
| Phenol Red: | With Phenol Red |
| Product Category: | Cell Culture Media |
| Product Type: | RPMI 1640 |
| Size: | Various |
| Sodium Pyruvate: | Without Sodium Pyruvate |
| Sterile: | Yes |
| Storage Temperature: | +2°C - +8°C |
| Manufacturer | PAN-Biotech GmbH |
| Country of Origin | Germany |
Documents
Product References
- Georg, Philipp et al. “Complement activation induces excessive T cell cytotoxicity in severe COVID-19.” Cell vol. 185,3 (2022): 493-512.e25. doi:10.1016/j.cell.2021.12.040
Ilex Life Sciences LLC is an authorized distributor of PAN-Biotech products.